Abstract

Several growth factors act in concert during liver regeneration in vivo. Once hepatic injury occurs, liver regeneration is stimulated by hepatocyte growth factor (HGF), transforming growth factor (TGF)-α, and heparin-binding epidermal growth factor-like growth factor (HB-EGF), whereas TGF-s1 terminates liver regeneration. Treatment with a combination of HGF and epidermal growth factor (EGF), in comparison with that with either HGF or EGF, was found to additively stimulate mitogen-activated protein kinase (MAPK) activity and cyclin D1 expression additively, resulting in additive stimulation of DNA synthesis. In contrast, TGF-s1 treatment completely inhibited DNA synthesis through a marked decrease in cyclin E expression, although growth factor-induced MAPK activity and cyclin D1 expression were not affected by TGF-s1. These results indicate that potent mitogens such as HGF, TGF-α, and HB-EGF can cooperatively induce the additive enhancement ofliver regeneration through an increase in Ras/MAPK activity followed by cyclin D1 expression, and that TGF-s1 suppresses the growth factor-induced signals between cyclin D1 and cyclin E, resulting in inhibition of DNA synthesis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call